granulomat
meningoencephalomyel
gme
necrot
meningoenceph
nme
progress
often
fatal
diseas
canin
central
nervou
system
cn
name
characterist
pattern
nonsuppur
inflamm
accompani
neuropatholog
although
extens
inform
exist
regard
clinic
patholog
featur
disord
underli
factor
contribut
diseas
develop
pathogenesi
remain
numer
etiopathogen
theori
suggest
includ
direct
cn
parainfecti
immun
genet
ultim
multifactori
etiopathogenesi
contribut
genet
environment
factor
consid
like
genet
predisposit
confirm
pug
dog
strongli
suspect
gme
base
overrepresent
diseas
small
contribut
environment
factor
identifi
either
disord
although
cn
infect
suspect
contribut
develop
gme
routin
diagnost
techniqu
cultur
microscopi
fail
identifi
protozo
fungal
bacteri
howev
comprehens
search
viral
atyp
bacteri
pathogen
sensit
molecular
lack
virus
document
caus
meningoencephalomyel
peopl
moreov
mycoplasma
edwardii
recent
report
caus
meningoenceph
investig
evalu
hypothesi
broadli
reactiv
pcr
may
aid
find
occult
viral
mycoplasma
infect
associ
gme
nme
brain
tissu
prospect
collect
case
histopatholog
confirm
gme
nme
evalu
presenc
known
novel
pathogen
broadli
reactiv
pcr
virus
addit
mycoplasma
pcr
retrospect
perform
collect
brain
tissu
case
gme
nme
identifi
dog
present
necropsi
texa
univers
colleg
veterinari
medicin
biomed
scienc
control
dog
identifi
concurr
includ
dog
ill
neurolog
ill
gme
nme
present
necropsi
gme
nme
case
evalu
singl
pathologist
bp
verifi
histopatholog
diagnosi
inclus
control
diagnos
pathologist
base
complet
necropsi
examin
age
diseas
onset
breed
sex
treatment
administ
surviv
time
record
time
sampl
collect
brain
tissu
collect
part
routin
necropsi
accord
institut
anim
care
use
guidelin
approxim
piec
tissu
collect
frontal
lobe
immedi
transfer
use
time
dog
death
sampl
acquisit
rang
hour
separ
steril
blade
petri
dish
use
collect
tissu
downstream
applic
addit
tissu
fix
formalin
histopatholog
immunohistochemistri
ihc
genom
dna
gdna
total
rna
extract
brain
store
aliquot
base
pair
bp
fragment
canin
histon
gene
amplifi
sampl
confirm
dna
rna
integr
confirm
sampl
revers
transcript
pcr
amplif
superoxid
dismutas
expect
product
size
bp
avoid
contamin
nucleic
acid
extract
pcr
prepar
preamplif
pcr
sequenc
carri
differ
room
neg
control
contain
dna
rna
templat
run
parallel
pcr
reaction
addit
mock
nucleic
acid
extract
steril
water
perform
parallel
clinic
case
util
neg
control
pcr
reaction
consensu
degener
hybrid
primer
use
broadli
reactiv
viral
pcr
support
inform
tabl
adenoviru
bunyaviru
coronaviru
flaviviru
paramyxoviru
seminest
herpesviru
pcr
snpcr
parechoviru
enteroviru
perform
accord
manufactur
instruct
final
volum
final
primer
concentr
unless
otherwis
note
reaction
contain
u
rnase
pcr
snpcr
reaction
use
deoxynucleotid
triphosp
dnpt
initi
reaction
perform
templat
dna
rna
seminest
reaction
perform
templat
initi
reaction
assay
individu
optim
sensit
determin
serial
dilut
plasmid
primer
use
describ
dna
canin
adenoviru
cav
templat
rna
human
parainfluenza
viru
use
posit
control
reaction
respect
previous
design
bunyaviru
primer
use
initi
reaction
minut
minut
minut
cycl
time
second
second
second
follow
final
elong
minut
rna
mutat
clone
la
cross
viru
lacv
use
posit
control
primer
sensit
determin
copi
target
gene
per
reaction
use
cach
valley
viru
lacv
previous
design
use
initi
reaction
use
seminest
reaction
revers
transcript
began
minut
minut
minut
follow
cycl
second
second
second
final
elong
minut
rna
human
coronaviru
use
posit
control
primer
sensit
determin
copi
target
gene
per
reaction
use
repres
virus
antigen
previous
design
flaviviru
mamd
use
initi
reaction
reaction
revers
transcript
began
minut
minut
minut
follow
cycl
second
second
minut
final
elong
minut
rna
mutat
clone
st
loui
enceph
sle
viru
use
posit
control
primer
sensit
determin
copi
target
gene
per
reaction
use
japanes
enceph
sle
dengu
west
nile
yellow
fever
virus
previous
design
dfasa
use
initi
reaction
vyga
use
seminest
reaction
reaction
began
initi
minut
follow
cycl
minut
minut
minut
final
elong
minut
dna
canin
herpesviru
type
use
posit
control
previous
design
parechoviru
enteroviru
primer
use
initi
reaction
minut
minut
cycl
time
follow
paramet
second
second
second
probe
detect
anneal
threshold
cycl
valu
determin
use
commerci
avail
templat
dna
human
parechoviru
harri
strain
echoviru
use
posit
control
parechoviru
enteroviru
respect
primer
sensit
determin
copi
human
parechoviru
copi
echoviru
mycoplasma
primer
design
amplifi
approxim
bp
region
ribosom
rna
rrna
gene
use
nest
final
volum
final
primer
concentr
dntp
initi
reaction
perform
primer
use
gdna
second
amplif
primer
use
templat
initi
reaction
reaction
began
initi
minut
follow
cycl
minut
minut
minut
final
elong
minut
dna
mycoplasma
oral
use
posit
control
cipher
singl
blind
brain
tissu
case
control
ship
overnight
dri
ice
bacteri
cultur
brain
tissu
homogen
incub
ambient
atmospher
condit
aac
ml
contain
wv
glucos
plu
wv
hour
inocul
media
pass
filter
remov
brain
homogen
potenti
environment
contamin
filtrat
inocul
onto
ga
agar
pass
ml
ga
broth
incub
aac
broth
agar
mycoplasm
growth
appar
individu
coloni
passag
broth
isol
identif
segreg
mix
infect
isol
presumpt
identifi
fragment
length
identif
confirm
direct
sequenc
rrna
gene
describ
ident
sampl
remain
blind
end
analysi
adenoviru
bunyaviru
coronaviru
flaviviru
herpesviru
paramyxoviru
mycoplasma
pcr
product
analyz
agaros
gel
electrophoresi
ethidium
bromid
stain
ultraviolet
exposur
amplicon
sequenc
purifi
amplicon
plasmid
use
correspond
amplif
primer
speci
defin
comparison
dna
sequenc
genbank
databas
entri
use
basic
local
align
search
tool
unconjug
lyophil
polyclon
antibodi
gener
rabbit
mycoplasma
cani
strain
use
ihc
cani
strain
coloni
agar
use
posit
control
neg
control
includ
agar
bacteria
well
edwardii
mycoplasma
spuman
grown
agar
brain
tissu
section
verifi
contain
inflammatori
lesion
case
gme
nme
optim
antibodi
stain
determin
occur
final
stain
time
minut
nonspecif
bind
minut
incub
primari
dilut
antibodi
univers
neg
two
system
use
horseradish
peroxidas
detect
system
endogen
peroxidas
activ
block
incub
hydrogen
peroxid
minut
primari
antibodi
incub
follow
addit
biotinyl
goat
antirabbit
horseradish
peroxidas
conjug
alkalin
phosphatas
detect
system
incub
primari
antibodi
follow
addit
biotinyl
label
alkalin
phosphatas
conjug
fast
slide
counterstain
gill
ii
blu
relationship
gme
nme
diagnosi
mycoplasma
pcr
cultur
posit
assess
fisher
exact
test
n
analysi
degre
freedom
n
student
perform
satterwaith
approxim
necessit
unequ
varianc
assess
relationship
clinic
paramet
age
diseas
onset
breed
sex
statu
treatment
administ
surviv
time
mycoplasma
pcr
cultur
posit
commerci
avail
softwar
use
signific
defin
p
brain
tissu
collect
gme
case
nme
case
control
dog
gme
case
includ
dachshund
labrador
retriev
airedal
terrier
bichon
frise
golden
retriev
maltes
shih
tzu
includ
femal
spay
male
neuter
rang
age
month
median
month
surviv
time
onset
clinic
sign
day
mean
rang
day
treatment
includ
antibiot
case
glucocorticoid
case
anticonvuls
drug
case
nme
case
includ
pug
dog
chihuahua
femal
spay
male
neuter
rang
age
month
median
month
mean
month
mean
surviv
time
onset
clinic
sign
day
rang
day
treatment
includ
antibiot
case
glucocorticoid
case
nonsteroid
immunosuppress
agent
case
anticonvuls
drug
case
control
includ
dog
variou
breed
ill
dog
neurolog
ill
gme
nme
astrocytoma
n
meningioma
n
canin
distemp
viru
cdv
enceph
n
disk
herniat
n
idiopath
mening
n
six
gme
case
nme
case
control
astrocytoma
meningioma
cdv
enceph
evalu
adenoviru
bunyaviru
coronaviru
enteroviru
flaviviru
herpesviru
paramyxoviru
parechoviru
pcr
viral
nucleic
acid
detect
amplif
cdv
nucleic
acid
primer
control
cdv
enceph
tabl
mycoplasma
pcr
perform
gme
case
nme
case
control
mycoplasma
dna
amplifi
dog
gme
dog
nme
control
parvovir
enter
tabl
support
inform
tabl
dna
gme
nme
case
share
sequenc
ident
cani
genbank
access
dna
remain
nme
case
share
sequenc
ident
mycoplasma
canimucosal
genbank
access
dna
control
share
sequenc
ident
spuman
genbank
access
statist
analysi
confirm
detect
cani
pcr
significantli
associ
diagnosi
gme
p
nme
p
next
gme
case
nme
case
control
previous
evalu
mycoplasma
pcr
cultur
fashion
substanti
pcr
find
cani
cultur
dog
gme
dog
nme
control
pulmonari
adenocarcinoma
coagulopathi
undetermin
origin
tabl
support
inform
tabl
although
isol
cani
commonli
associ
case
gme
nme
control
result
statist
signific
addit
gme
nme
case
second
mycoplasma
speci
identifi
edwardii
gme
nme
case
spuman
nme
case
spuman
cultur
dog
system
parvovir
infect
posit
spuman
via
mycoplasma
pcr
tabl
ihc
perform
determin
cani
could
detect
situ
case
gme
nme
ihc
detect
cani
gme
nme
control
evalu
tabl
addit
signific
associ
clinic
paramet
case
gme
nme
presenc
mycoplasma
cani
detect
pcr
cultur
use
broadli
reactiv
pcr
found
evid
viral
nucleic
acid
brain
tissu
dog
histopatholog
confirm
gme
nme
contrast
use
pcr
cultur
cani
identifi
gme
nme
case
result
suggest
viral
infect
associ
commonli
gme
nme
highlight
need
evalu
role
cani
disord
sever
investig
specul
possibl
role
virus
pathogenesi
gme
comprehens
search
viral
pathogen
lack
evalu
tissu
histopatholog
confirm
gme
nme
case
divers
collect
virus
use
broadli
reactiv
pcr
identifi
unknown
well
known
comprehens
natur
investig
support
virus
commonli
associ
gme
nme
sever
limit
must
consid
includ
small
sampl
size
method
time
sampl
collect
lack
standard
tissu
pcr
control
use
noncanin
virus
pcr
control
case
tissu
collect
frontal
lobe
may
may
result
direct
sampl
inflammatori
lesion
addit
pcr
assay
util
rang
sensit
copi
target
gene
per
reaction
may
preclud
identif
low
viral
load
importantli
howev
pcr
assay
util
demonstr
util
identifi
virus
associ
canin
cn
fulli
util
gme
nme
tissu
collect
investig
mycoplasma
pcr
perform
addit
viral
screen
interestingli
sever
mycoplasma
speci
regularli
associ
respiratori
tract
dog
identifi
detect
cani
pcr
significantli
associ
diagnosi
gme
nme
although
cani
associ
respiratori
urogenit
report
cani
associ
cn
diseas
nervou
tissu
speci
import
find
cani
associ
gme
nme
unclear
cani
detect
situ
detect
control
contamin
nonasept
tissu
collect
rule
howev
contamin
sole
explan
find
cani
would
expect
occur
equal
frequenc
gme
nme
case
control
addit
polyclon
sera
use
ihc
dilut
significantli
avoid
background
may
contribut
neg
result
obtain
assay
altern
cani
may
associ
primari
diseas
pathogenesi
may
present
secondari
previous
exist
diseas
patient
immunosuppress
interestingli
mycoplasma
pneumonia
implic
common
yet
elus
etiolog
acut
childhood
diseas
similar
clinic
neuropatholog
featur
gme
nme
also
favor
clinic
respons
immunosuppress
therapi
also
gme
nme
case
receiv
antibiot
tissu
collect
may
alter
abil
detect
recov
mycoplasma
case
note
mycoplasma
speci
identifi
sever
case
could
support
contamin
ubiquit
organ
repres
coinfect
similar
mycoplasma
synovia
mycoplasma
meleagridi
also
noteworthi
cn
mycoplasmosi
involv
speci
result
suppur
typic
featur
gme
nme
patholog
howev
without
better
understand
patholog
process
drive
gme
nme
role
cani
exclud
mycoplasma
infrequ
associ
cn
virul
factor
would
allow
cani
invad
colon
cn
unknown
interestingli
neuraminidas
activ
recent
identifi
neuraminidas
virul
factor
possess
wide
varieti
bacteri
speci
shown
promot
pathogen
colon
invas
damag
host
recent
identifi
critic
bacteri
entri
cn
streptococcu
pneumonia
genet
suscept
cani
infect
also
must
missens
mutat
predispos
peopl
acut
necrot
encephalopathi
recent
suscept
certain
pathogen
also
like
possibl
genet
immunosuscept
cani
infect
may
contribut
multifactori
etiopathogenesi
dog
develop
gme
nme
genet
differ
also
may
explain
cani
infect
could
associ
gme
nme
despit
neuropatholog
distinct
summari
broadli
reactiv
pcr
use
evalu
histopatholog
confirm
case
gme
nme
viral
pathogen
mycoplasma
result
support
virus
evalu
commonli
associ
gme
nme
suggest
possibl
role
cani
diseas
pathogenesi
although
contamin
rule
base
result
investig
find
import
identif
infecti
agent
contribut
gme
nme
pathogenesi
could
favor
alter
diseas
diagnosi
treatment
outcom
next
step
includ
develop
monoclon
cani
antibodi
local
cani
via
situ
hybrid
prospect
survey
cani
asept
collect
gme
nme
brain
tissu
cerebrospin
fluid
